CRP and hepatocellular carcinoma: There is increasing evidence showing that the presence of a systemic inflammatory response, as indicated by an elevated circulating C-reactive protein (CRP) concentration, is associated with poor survival in patients with malignancy, including HCC (Hashimoto et al, 2005; Nagaoka et al, 2007).